Highlights of Ophthalmology

Register      Login

VOLUME 40 , ISSUE 6ENG ( Dec-2012, 2012 ) > List of Articles

REVIEW ARTICLE

Stopping Progression of Optic Disk Damage and Preserving Visual Fields in Glaucoma Patients

María Eugenia Gilbert Lucido

Citation Information : Lucido ME. Stopping Progression of Optic Disk Damage and Preserving Visual Fields in Glaucoma Patients. 2012; 40 (6ENG):13-15.

DOI: 10.5005/hoo-10101-40603

Published Online: 25-12-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

PDF Share
  1. Sultan MB, Mansberger SL, Lee PP. Understanding the importance of OIP variables in glaucoma: a systematic review. Surv Ophthalmol, 2009 Nov-Dec;54(6):643-62.
  2. Detry-Morel M. Currents on target intraocular pressure and intraocular pressure fluctuations in glaucoma management. Bull Soc Belge Ophthalmol, 2008;(308):35-43.
  3. Heijl A, Leske MD, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results form de Early Manifest Glaucoma Trial. Arch Ophthalmol, 2002; 120:1268-127.
  4. Drance SM. Diurnal variation of intraocular pressure in treated glaucoma. Arch Ophthalmol, 1963;70:302-311.
  5. Magacho L, Toscano DA, Freire G, Shetty RK, Avila MP. Comparing the measurement of diurnal fluctuations in intraocular pressure in the same day versus over different days in glaucoma. Eur J Ophthalmol, 2010 May-Jun;20(3):242-5.
  6. Fogagnolo P, Orzalesi N, Ferreras A, Rossetti L. The circadian curve of intraocular pressure: can we estímate its characteristics during office hours? Invest Ophthalmol Vis Sci, 2009 May;50(5):2209-15.
  7. Chiselita D, Motoc I, Danielescu C. Daily and nightly fluctuation of intraocular pressure and blood pressure in glaucoma and non-glaucoma patients. Oftalmologia, 2008;52(1):119- 25.
  8. Singh K, Shrivastava A. Intraocular pressure fluctuations: how much do they matter? Curr Opin Ophthalmol, 2009 Mar;20(2):84-7.
  9. AGIS investigators. The Advanced Glaucoma Intervention Study. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol, 2000;130:429-440.
  10. Stewart WC, Konstas AG, Kruft B, Mathis HM, Stewart JA. Meta-analysis of 24-h intraocular pressure fluctuation studies and the efficacy of glaucoma medicines. J Ocul Pharmacol Ther, 2010 Apr;26(2):175-80.
  11. Werne A, Harris A, Moore D, BenZion I, Siesky B. The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: risk factors for glaucoma? Surv Ophthalmol, 2008 Nov-Dec;53(6):559-67.
  12. Schmidl D, Garhofer G, Schmetterer L. The complex interaction between ocular perfusion pressure and ocular blood flow - Relevance for glaucoma. Exp Eye Res, 2010 Sep; 22.
  13. Martínez A, Sanchez-Salorio M. Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma. Acta Ophthalmol, 2010 Aug;88(5):541-52.
  14. Costa VP, Arcieri ES, Harris A. Blood pressure and glaucoma. BR J Ophthalmol, 2009 OCT;93(10):1276-82.
  15. Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol, 2008 Nov;53 Suppl 1:S3-10.
  16. Zhang L, Su L, Yang H. Risk factors and the progress of primary open-angle glaucoma. Abstract Zhonghua Yan Ke Za Zhi 2009 Apr;45(4):380-4.
  17. Teng CC, De Moraes CG et al. Beta-Zone parapapillary atrophy and the velocitiy of glaucoma progression. Ophthalmology 2010 May;117(5):909-15.
  18. Chauhan BC, Mikelberg FS, Artes PH, et al. Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change. Arch Ophthalmol 201 Oct;128(10):1249-55.
  19. Zanon-Moreno V, Garcia-Medina JJ et al. Smoking, an additional risk factor in elder women with primary open-angle glaucoma. Mol Vis, 2009 Dec 31;15:2953-9.
  20. Tezel G. The immune response in glaucoma: A perpective on the roles of oxidative stress. Exp Eye Res, 2010 Aug 13.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.